Anlon Healthcare Ltd vs Chemplast Sanmar Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 121.35 as of 20 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Chemplast Sanmar Ltd changed from 16.2 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Chemplast Sanmar Ltd changed from ₹ 10506 crore on March 2022 to ₹ 6892 crore on March 2025 . This represents a CAGR of -10.00% over 4 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Chemplast Sanmar Ltd for the Dec '25 is ₹ 840.52 crore as compare to the Sep '25 revenue of ₹ 1040 crore. This represent the decline of -19.2% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Chemplast Sanmar Ltd for the Dec '25 is ₹ -51.37 crore as compare to the Sep '25 ebitda of ₹ 50.24 crore. This represent the decline of -202% The net profit of Anlon Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Chemplast Sanmar Ltd changed from ₹ 23.89 crore to ₹ -119 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Chemplast Sanmar Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Chemplast Sanmar Ltd

Chemplast Sanmar Limited, formerly known as Chemicals & Plastics India Limited, incorporated in 1985.
The Company was initially promoted as 'Urethanes India' a subsidiary of Chemplast, the flagship company of the Sanmar Group, Tamil Nadu.
Later, it became a fully-owned subsidiary of Chemplast in 1991 when Chemicals & Plastics India Limited was changed to 'Chemplast Sanmar Limited' on September 28, 1995. The Company is a leading speciality chemicals manufacturer with focus on speciality paste PVC resin and custom manufacturing of starting materials and intermediates for pharmaceutical, agro-chemical and fine chemicals sectors.
It is the largest manufacturer of Speciality Paste PVC Resin In addition, it is the fourth largest manufacturer of Caustic Soda and largest manufacturer of Hydrogen Peroxide in South India and one of the oldest manufacturers of Chloromethanes in India.

FAQs for the comparison of Anlon Healthcare Ltd and Chemplast Sanmar Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Chemplast Sanmar Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of Chemplast Sanmar Ltd is 4,432 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Chemplast Sanmar Ltd?

The stock performance of Anlon Healthcare Ltd and Chemplast Sanmar Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Chemplast Sanmar Ltd?

As of March 22, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, Chemplast Sanmar Ltd stock price is INR ₹280.35.

How do dividend payouts of Anlon Healthcare Ltd and Chemplast Sanmar Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Chemplast Sanmar Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.